コンテンツへスキップ
· スキンブースター
SKU 11116

Revanesse Renew ™+

In stock
Volume
2 x 1,2 mL
Laboratory
Prollenium Medical Technologies Inc.
Origin
カナダ
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Made by Prollenium Medical Technologies in Aurora, Canada, Revanesse Renew+ is a clear, water-based gel of synthetic origin with no colour and no odour, created for the treatment of facial rhytides and lipoatrophy. Practitioners inject it into the skin, and its implantation life averages 4 weeks. With 14 mg/mL of hyaluronic acid and 0.3% lidocaine in phosphate-buffered saline, it sits at a light concentration within the Revanesse range and is intended for professional use. Each box contains two 1.2 mL syringes with up to two sterilised needles.

*Note: This product may have market-specific regulatory status and availability. Please contact ALLPARA to confirm availability for your market.

主なメリット: Revanesse Renew ™+

  • Hyaluronic acid 14 mg/mL, a light concentration within the Revanesse range
  • 0.3% lidocaine for injection comfort
  • Placed at the most superficial layer of the skin
  • Indicated for facial rhytides and lipoatrophy
  • Supplied as two 1.2 mL pre-filled syringes with up to two sterilised needles
  • Implantation life averages 4 weeks, suiting a repeated skin-quality regimen
主な情報
ブランド REVANESSE
製造元 Prollenium Medical Technologies Inc.
原産国 Canada
成分 Hyaluronic acid 14 mg/mL; lidocaine 0.3% w/w; in phosphate-buffered saline
容量 / サイズ 1.2 ml
包装 2 pre-filled syringes x 1.2 mL, with up to two sterilised needles
使用タイプ For professional use: injectable hyaluronic acid gel with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
注入の深さ Injection into the skin, at its most superficial layer. Injection depth, treatment areas and indications may differ by country, region or territory, and are determined by the treating practitioner.
プロトコル / 期間 Implantation life averages 4 weeks, depending on the depth and location of injection

適応と専門的な使用

主な適応

  • Facial rhytides
  • Lipoatrophy

専門的な使用

For professional use. Revanesse Renew+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is injected into the skin at its most superficial layer; injection depth, treatment areas and indications may differ by country, region or territory and are determined by the treating practitioner. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.

施術部位

  • Face

対象となる患者

For adult patients seeking treatment of facial rhytides or lipoatrophy at skin level, as assessed by a qualified physician. Contraindications include hypersensitivity to amide-type local anaesthetics, hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.

作用の仕組み: Revanesse Renew ™+ ​

Renew+ works at the skin rather than in the deeper planes the rest of the range occupies. At 14 mg/mL it carries roughly half the hyaluronic acid of Contour+ or Sculpt+, and it is placed at the most superficial layer of the skin, which is why its implantation life is around 4 weeks rather than the 6 to 12 months of the volumising references. It is a treatment to be repeated as part of a skin-quality regimen rather than a single volumising correction, and the 0.3% lidocaine is present for injection comfort.

Allparaで注文する理由

Allparaは、正規品で検証済みの REVANESSE 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問

Why does Revanesse Renew ™+ last so much less time than the other Revanesse references?

Because it does a different job. At 14 mg/mL placed at the most superficial layer of the skin, its implantation life averages 4 weeks, against 6 to 12 months for the 25 mg/mL volumising references placed in the dermis. It is intended as a repeatable skin-quality treatment rather than a single volumising correction.

Does Revanesse Renew ™+ contain an anaesthetic?

Yes, 0.3% lidocaine, carried in phosphate-buffered saline alongside the hyaluronic acid. Hypersensitivity to lidocaine or to any amide-type local anaesthetic is therefore a contraindication.

その他の製品: Prollenium Medical Technologies

View laboratory

Clinic alternatives

All products

Revanesse Renew ™+

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Made by Prollenium Medical Technologies in Aurora, Canada, Revanesse Renew+ is a clear, water-based gel of synthetic origin with no colour and no odour, created for the treatment of facial rhytides and lipoatrophy. Practitioners inject it into the skin, and its implantation life averages 4 weeks. With 14 mg/mL of hyaluronic acid and 0.3% lidocaine in phosphate-buffered saline, it sits at a light concentration within the Revanesse range and is intended for professional use. Each box contains two 1.2 mL syringes with up to two sterilised needles.

*Note: This product may have market-specific regulatory status and availability. Please contact ALLPARA to confirm availability for your market.

主なメリット: Revanesse Renew ™+

  • Hyaluronic acid 14 mg/mL, a light concentration within the Revanesse range
  • 0.3% lidocaine for injection comfort
  • Placed at the most superficial layer of the skin
  • Indicated for facial rhytides and lipoatrophy
  • Supplied as two 1.2 mL pre-filled syringes with up to two sterilised needles
  • Implantation life averages 4 weeks, suiting a repeated skin-quality regimen
主な情報
ブランド REVANESSE
製造元 Prollenium Medical Technologies Inc.
原産国 Canada
成分 Hyaluronic acid 14 mg/mL; lidocaine 0.3% w/w; in phosphate-buffered saline
容量 / サイズ 1.2 ml
包装 2 pre-filled syringes x 1.2 mL, with up to two sterilised needles
使用タイプ For professional use: injectable hyaluronic acid gel with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
注入の深さ Injection into the skin, at its most superficial layer. Injection depth, treatment areas and indications may differ by country, region or territory, and are determined by the treating practitioner.
プロトコル / 期間 Implantation life averages 4 weeks, depending on the depth and location of injection

適応と専門的な使用

主な適応

  • Facial rhytides
  • Lipoatrophy

専門的な使用

For professional use. Revanesse Renew+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is injected into the skin at its most superficial layer; injection depth, treatment areas and indications may differ by country, region or territory and are determined by the treating practitioner. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.

施術部位

  • Face

対象となる患者

For adult patients seeking treatment of facial rhytides or lipoatrophy at skin level, as assessed by a qualified physician. Contraindications include hypersensitivity to amide-type local anaesthetics, hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.

作用の仕組み: Revanesse Renew ™+ ​

Renew+ works at the skin rather than in the deeper planes the rest of the range occupies. At 14 mg/mL it carries roughly half the hyaluronic acid of Contour+ or Sculpt+, and it is placed at the most superficial layer of the skin, which is why its implantation life is around 4 weeks rather than the 6 to 12 months of the volumising references. It is a treatment to be repeated as part of a skin-quality regimen rather than a single volumising correction, and the 0.3% lidocaine is present for injection comfort.

Allparaで注文する理由

Allparaは、正規品で検証済みの REVANESSE 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。

よくある質問

Why does Revanesse Renew ™+ last so much less time than the other Revanesse references?

Because it does a different job. At 14 mg/mL placed at the most superficial layer of the skin, its implantation life averages 4 weeks, against 6 to 12 months for the 25 mg/mL volumising references placed in the dermis. It is intended as a repeatable skin-quality treatment rather than a single volumising correction.

Does Revanesse Renew ™+ contain an anaesthetic?

Yes, 0.3% lidocaine, carried in phosphate-buffered saline alongside the hyaluronic acid. Hypersensitivity to lidocaine or to any amide-type local anaesthetic is therefore a contraindication.

その他の製品: Prollenium Medical Technologies

ラボを見る →
* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.